Kinetics of inflammatory response of astrocytes induced by TLR3 and TLR4 ligation

Journal of Neuroscience Research

Volumn 85, Issue 1, 2007, Pages 205-212

  Krasowska Zoladek, Alicja ^a   Banaszewska, Monika ^a   Kraszpulski, Michal ^a   Konat, Gregory W ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Double stranded RNA; Lipopolysaccharide; Nitric oxide; Signal transduction pathways

Indexed keywords

BETA INTERFERON; CYTOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIGAND; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; LYMPHOTOXIN BETA; NITRIC OXIDE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; CELL KINETICS; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; LIGATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; INFLAMMATION; LIGANDS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, DOUBLE-STRANDED; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 33846146647     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21088     Document Type: Article

References (47)

1. Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A, Morris C, Winblad B, Nordberg A, Zhu J. 2002. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol 126:50-57.
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
3. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
4. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
5. Anfossi G, Massucco P, Mattiello L, Balbo A, Russo I, Doronzo G, Rolle L, Ghigo D, Fontana D, Bosia A, Trovati M. 2002. Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. Eur J Endocrinol 147:689-700.
6. Baetz A, Frey M, Heeg K, Dalpke AH. 2004. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem 279:54708-54715.
7. Benveniste EN. 1997. Cytokines: influence on glial cell gene expression and function. In: Blalock JE, editor. Neuroimmunoendocrinology. Basel: S Karger. p 31-75.
8. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029.
9. Bosisio D, Polentarutti N, Sironi M, Bemasconi S, Miyake K, Webb GR, Martin MU, Mantovani A, Muzio M. 2002. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99:3427-3431.
10. Bowman CC, Rasley A, Tranguch SL, Marriott I. 2003. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281-291.
11. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021.
12. Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005.
13. Carballo E, Lai WS, Blackshear PJ. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deacetylation and stability. Blood 95:1891-1899.
14. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374.
15. Clark DA, Coker R. 1998. Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 30:293-298.
16. Cole R, de Vellis J. 1997. Astrocyte and oligodendrocyte cultures. In: Fedoroff S, Richardson A, editors. Protocols for neural culture. Totowa, NJ: Humana Press. p 117-130.
17. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. 1992. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410.
18. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson GE, Job TH. 1999. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 67:46-52.
19. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
20. Doyle SE, Vaidya SA, O'Connell R, Dadgostar H, Dempsey PW, Wu TT, Rao G, Sun R, Haberland ME, Modlin RL, Cheng G. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263.
21. Fan H, Cook JA. 2004. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10:71-84.
22. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 159:12-19.
23. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198:1043-1055.
24. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330.
25. Jacobs BL, Langland JO. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
26. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233-5239.
27. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279:12542-12550.
28. Kariko K, Weissman D, Welsh FA. 2004. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288-304.
29. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202.
30. Lavista Llanos S, Roldan A. 1999. Effect of dexamethasone on nitric oxide (NO.) production by cultured astrocytes. Biocell 23:29-35.
31. Ma L, Morita I, Murota S. 1994. Presence of constitutive type nitric oxide synthase in cultured astrocytes isolated from rat cerebra. Neurosci Lett 174:123-126.
32. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. 2001. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22:328-336.
33. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
34. Newman E, Spratt DE, Mosher J, Cheyne B, Montgomery HJ, Wilson DL, Weinberg JB, Smith M, Salerno JC, Ghosh DK, Guillemette JG. 2004. Differential activation of nitric oxide synthase isozymes by calmodulin-troponin C chimeras. J Biol Chem 279:33547-33557.
35. Ogata A, Nishihira J, Suzuki T, Nagashima K, Tashiro K. 1998. Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization. Neurosci Lett 246:173-177.
36. Ogata M, Okamoto K, Kohriyama K, Kawasaki T, Itoh H, Shigematsu A. 2000. Role of interleukin-10 on hyporesponsiveness of endotoxin during surgery. Crit Care Med 28:3166-3170.
37. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
38. Park J, Kwon D, Choi C, Oh JW, Benveniste EN. 2003. Chloroquine induces activation of nuclear factor-kappaB and subsequent expression of pro-inflammatory cytokines by human astroglial cells. J Neurochem 84:1266-1274.
39. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
40. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A. 2005. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102:9577-9582.
41. Scumpia PO, Kelly KM, Reeves WH, Stevens BR. 2005. Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52:153-162.
42. Smiley ST, King JA, Hancock WW. 2001. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167:2887-2894.
43. Tashiro H, Dohura K, Iwaki T. 1998. Differential expression of transforming growth factor-beta isoforms in human prion diseases. Neuropathol Appl Neurobiol 24:284-292.
44. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079-17084.
45. Vabulas RM, Wagner H, Schild H. 2002. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 270:169-184.
46. Wells CA, Ravasi T, Hume DA. 2005. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol 78:9-13.
47. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4:1144-1150.